A second national questionnaire survey of TMA. (Q33389912)

26 July 2017

A second national questionnaire survey of TMA. (English)

1 reference

26 July 2017

1 reference

Naomi Ito-Habe

1

1 reference

26 July 2017

Hideo Wada

2

1 reference

26 July 2017

Masanori Matsumoto

3

1 reference

26 July 2017

Yoshihiro Fujimura

4

1 reference

26 July 2017

Mitsuru Murata

5

1 reference

26 July 2017

Takashi Izuno

6

1 reference

26 July 2017

Minoru Sugita

7

1 reference

26 July 2017

Yasuo Ikeda

8

1 reference

26 July 2017

5 June 2010

1 reference

International Journal of Hematology

26 July 2017

1 reference

26 July 2017

92

1 reference

26 July 2017

1

1 reference

26 July 2017

68-75

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-010-0599-4

26 July 2017

0 references

cites work

THROMBOTIC THROMBOCYTOPENIC PURPURA

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0599-4

A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0599-4

Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond

21 January 2018

1 reference

12 December 2020

Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen

1 reference

12 December 2020

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

12 December 2020

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

1 reference

12 December 2020

The management of thrombotic thrombocytopenic purpura in 2005.

1 reference

12 December 2020

Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity

1 reference

12 December 2020

Thrombotic Microangiopathies

1 reference

12 December 2020

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

12 December 2020

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement

1 reference

12 December 2020

National questionnaire survey of TMA.

1 reference

12 December 2020

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.

1 reference

12 December 2020

Management of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.

1 reference

12 December 2020

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay

1 reference

12 December 2020

Current insight into thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange

1 reference

12 December 2020

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan

1 reference

12 December 2020

A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.

1 reference

12 December 2020

Therapeutic plasma exchange plus corticosteroid for the treatment of the thrombotic thrombocytopenic purpura: a single institutional experience in the southern Marmara region of Turkey

1 reference

12 December 2020

10.1007/S12185-010-0599-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference